Femasys Inc (FEMY NASDAQ) stock market data APIs
$0.9387
0.05(5.3%)
as of July 1, 2025
Try our APIs with
free plan!
Femasys Inc Financial Data Overview
Price chart is built with
Anychart
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Prev. Close
0.9387
Open
0.9884
High
0.9884
Low
0.9157
52 wk Range
0.693-1.8
Market Cap
31 414 K
Shares Outstanding
32 526 K
Revenue
1 699 K
EPS
-0.23
Beta
-2.614
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Femasys Inc data using free add-ons & libraries
Get Femasys Inc Fundamental Data
Femasys Inc Fundamental data includes:
- Net Revenue: 1 699 K
- EBITDA: -19 472 828
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-09
- EPS/Forecast: -0.19
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Femasys Inc News
New
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
-- Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed® -- ATLANTA, June 11, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a lea...
Femasys announces pricing of underwritten public offering and concurrent private placement with gross proceeds of $4.5M
* Femasys (NASDAQ:FEMY [https://seekingalpha.com/symbol/FEMY]) on Friday announced the pricing of an underwritten public offering of 3.6M shares of its common stock at a public offering price of $0....
Femasys announces public offering, concurrent private placement
* Femasys (NASDAQ:FEMY [https://seekingalpha.com/symbol/FEMY]) plans to sell common stock in an underwritten public offering. A 30-day option will be granted to underwriters to purchase up to 15% ad...
Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s health worl...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
